Form 4 for HAE HAEMONETICS CORP
Accepted 2023-09-13 00:00:00 ET · period of report 2023-09-11 · accession 0001127602-23-024071 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-13 | 2023-09-11 | HAE | Lingamneni Anila | EVP, CTO | S - Sale | $90.00 | -2,305 | 14.5K | -14% | -$207.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-11 | S | D | 2,305 | $90.00 | 14,495 | D | — | — | (F2) This number includes unvested restricted stock units previously reported. |